Table 3. Side effects analysis among both groups.
| Side effect | Methocarbamol group (no. 55) | Nefopam group (no. 55) | P-value |
| Nausea | 1 (1.8%) | 2 (3.6%) | 0.628 |
| Vomiting | 0 (0.0%) | 1 (1.8%) | 0.315 |
| Tachycardia | 5 (9.09%) | 12 (21.81%) | 0.003 |
| Side effect | Methocarbamol group (no. 55) | Nefopam group (no. 55) | P-value |
| Nausea | 1 (1.8%) | 2 (3.6%) | 0.628 |
| Vomiting | 0 (0.0%) | 1 (1.8%) | 0.315 |
| Tachycardia | 5 (9.09%) | 12 (21.81%) | 0.003 |